rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2008-1-7
|
pubmed:databankReference |
|
pubmed:abstractText |
Preclinical data have suggested a synergistic effect of cetuximab combined with gemcitabine and cisplatin and clinical data have shown a substantial improvement in response and survival when gemcitabine is combined with a platinum analogue compared with gemcitabine alone. The aim of this study was to assess the activity and feasibility of a combination of cetuximab with gemcitabine and cisplatin compared with use of gemcitabine and cisplatin alone for the treatment of advanced pancreatic cancer.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1474-5488
|
pubmed:author |
pubmed-author:AitiniEnricoE,
pubmed-author:ArtaleSalvatoreS,
pubmed-author:BarniSandroS,
pubmed-author:BerardiRossanaR,
pubmed-author:CascinuStefanoS,
pubmed-author:DaprettoElisaE,
pubmed-author:Di CostanzoFrancescoF,
pubmed-author:FalconeAlfredoA,
pubmed-author:FlorianiIreneI,
pubmed-author:Italian Group for the Study of Digestive Tract Cancer (GISCAD),
pubmed-author:LabiancaRobertoR,
pubmed-author:PierantoniChiaraC,
pubmed-author:RotaSilviaS,
pubmed-author:ScartozziMarioM,
pubmed-author:SienaSalvatoreS,
pubmed-author:ToniniGiuseppeG,
pubmed-author:ZaniboniAlbertoA
|
pubmed:issnType |
Electronic
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
39-44
|
pubmed:meshHeading |
pubmed-meshheading:18077217-Adult,
pubmed-meshheading:18077217-Aged,
pubmed-meshheading:18077217-Antibodies, Monoclonal,
pubmed-meshheading:18077217-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18077217-Cisplatin,
pubmed-meshheading:18077217-Deoxycytidine,
pubmed-meshheading:18077217-Disease-Free Survival,
pubmed-meshheading:18077217-Female,
pubmed-meshheading:18077217-Follow-Up Studies,
pubmed-meshheading:18077217-Humans,
pubmed-meshheading:18077217-Male,
pubmed-meshheading:18077217-Middle Aged,
pubmed-meshheading:18077217-Pancreatic Neoplasms
|
pubmed:year |
2008
|
pubmed:articleTitle |
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial.
|
pubmed:affiliation |
Polytechnic University of Marche-Riuniti Hospital Umberto I-GM Lancisi-G Salesi of Ancona, 60020 Ancona, Italy. cascinu@yahoo.com
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase II
|